Oramed Pharmaceuticals Appoints New CEO and VP of Business Development

Tue, 04/16/2013 - 9:31am

Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, today announced a key addition to its executive leadership team with the appointment of Joshua Hexter as Chief Operating Officer and Vice President of Business Development.

"Josh will be a great addition and complement to Oramed's executive team as we enter a new era in our clinical trials and activities," commented Oramed CEO Nadav Kidron.

Mr. Hexter brings to Oramed more than 15 years of prominent leadership with a commitment to excellence in the biotech industry in business development and operations. Most recently he was Executive Director of Corporate In-Licensing at BioLineRx. Mr. Hexter received his B.A. from the University of Wisconsin and his Masters in Business Management from Boston University.




Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.